Terns Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 8.14 M | $45.11 M | 30.83% | 10.46% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 7.56 M | $41.90 M | 0.00% | 9.72% |
| VIVO CAPITAL, LLC | 02/13/2025 | 6.90 M | $38.20 M | 0.00% | 8.86% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 5.74 M | $31.82 M | 22.23% | 7.38% |
| DEEP TRACK CAPITAL, LP | 02/14/2025 | 5.58 M | $30.89 M | 0.00% | 7.17% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 4.75 M | $26.32 M | 44.43% | 6.11% |
| VANGUARD GROUP INC | 02/11/2025 | 3.87 M | $21.44 M | 15.28% | 4.97% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 2.63 M | $14.59 M | 30.59% | 3.38% |
| CANDRIAM S.C.A. | 02/07/2025 | 2.15 M | $11.93 M | 100.00% | 2.77% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 02/14/2025 | 2.02 M | $11.19 M | 49.83% | 2.60% |
| 02/14/2025 | 1.97 M | $10.92 M | 100.00% | 2.53% | |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.66 M | $9.21 M | -20.55% | 2.14% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 1.61 M | $8.92 M | 2.01% | 2.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.52 M | $8.40 M | 25.59% | 1.95% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 1.50 M | $8.34 M | 1.94% | 1.93% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 1.30 M | $7.22 M | 107.02% | 1.67% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 1.25 M | $6.94 M | -53.76% | 1.61% |
| VR ADVISER, LLC | 02/14/2025 | 1.08 M | $5.97 M | -68.41% | 1.38% |
| BELLEVUE GROUP AG | 02/14/2025 | 1.06 M | $5.88 M | 1.88% | 1.36% |
| NORGES BANK | 02/12/2025 | 849,389 | $4.71 M | 100.00% | 1.09% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/14/2025 | 829,105 | $4.59 M | 51.92% | 1.07% |
| MARSHALL WACE, LLP | 02/13/2025 | 803,336 | $4.45 M | 666.85% | 1.03% |
| 02/14/2025 | 752,000 | $4.17 M | 100.00% | 0.97% | |
| BARCLAYS PLC | 02/13/2025 | 704,371 | $3.90 M | 642.21% | 0.91% |
| RUSSELL INVESTMENTS GROUP, LTD. | 02/13/2025 | 628,395 | $3.48 M | -15.62% | 0.81% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 623,134 | $3.45 M | 29.96% | 0.80% |
| ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 475,000 | $2.63 M | 43.94% | 0.61% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 450,000 | $2.49 M | 50.00% | 0.58% |
| ACUTA CAPITAL PARTNERS, LLC | 02/14/2025 | 447,500 | $2.48 M | -8.11% | 0.58% |
| UBS GROUP AG | 02/14/2025 | 401,658 | $2.23 M | 478.77% | 0.52% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 398,379 | $2.21 M | -26.61% | 0.51% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 362,359 | $2.01 M | 48.16% | 0.47% |
| SALEM INVESTMENT COUNSELORS INC | 01/13/2025 | 346,725 | $1.92 M | -7.93% | 0.45% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 343,050 | $1.90 M | -18.10% | 0.44% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 314,389 | $1.74 M | -31.20% | 0.40% |
| WOODLINE PARTNERS LP | 02/14/2025 | 311,612 | $1.73 M | 3.45% | 0.40% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 308,491 | $1.71 M | 0.00% | 0.40% |
| TREXQUANT INVESTMENT LP | 02/12/2025 | 253,247 | $1.40 M | -16.67% | 0.33% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 249,900 | $1.38 M | 0.32% | 0.32% |
| J. GOLDMAN & CO LP | 02/14/2025 | 235,831 | $1.31 M | 15.64% | 0.30% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 224,265 | $1.24 M | 100.00% | 0.29% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 222,514 | $1.23 M | 0.20% | 0.29% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 206,450 | $1.14 M | 33.44% | 0.27% |
| SAMSARA BIOCAPITAL, LLC | 02/14/2025 | 202,348 | $1.12 M | 0.00% | 0.26% |
| 02/26/2025 | 200,000 | $1.11 M | 100.00% | 0.26% | |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 186,308 | $1.03 M | 15.45% | 0.24% |
| POLYMER CAPITAL MANAGEMENT (HK) LTD | 02/13/2025 | 177,000 | $980,580 | 637.50% | 0.23% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 150,000 | $831,000 | 0.00% | 0.19% |
| EXCHANGE TRADED CONCEPTS, LLC | 01/21/2025 | 142,919 | $791,771 | 34.13% | 0.18% |
| UBS OCONNOR LLC | 02/14/2025 | 140,300 | $777,262 | 192.29% | 0.18% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Terns Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 188 institutional investors and hedge funds held shares of Terns Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Soleus Capital Management, L.P.: 8.14 M
ORBIMED ADVISORS LLC: 7.56 M
Vivo Capital, LLC: 6.9 M
BlackRock Funding, Inc. /DE: 5.74 M
Deep Track Capital, LP: 5.58 M
Schonfeld Strategic Advisors LLC: 4.75 M
110.67% of Terns Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 84.71 M shares in the last 24 months. This purchase volume represents approximately $483.71 M in transactions.